(Q44212285)

30 November 2017

title

Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease (English)

1 reference

30 November 2017

1 reference

1 reference

Meredith GE

1 reference

30 November 2017

Totterdell S

1 reference

30 November 2017

Petroske E

1 reference

30 November 2017

Santa Cruz K

1 reference

30 November 2017

Callison RC Jr

1 reference

30 November 2017

Lau YS

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

30 November 2017

1 reference

inferred from page(s)

published in

Brain Research

1 reference

30 November 2017

volume

956

1 reference

30 November 2017

1 reference

30 November 2017

page(s)

156-165

1 reference

Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Experimental models of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Impairment of the ubiquitin-proteasome system by protein aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Degradation of alpha-synuclein by proteasome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Synucleins in synaptic plasticity and neurodegenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Synthetic filaments assembled from C-terminally truncated alpha-synuclein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

A Drosophila model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Alz-50/Gallyas-positive lysosome-like intraneuronal granules in Alzheimer's disease and control brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Inhibitors of lysosomal enzymes: accumulation of lipofuscin-like dense bodies in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

The rat brain synucleins; family of proteins transiently associated with neuronal membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Ubiquitin, lysosomes, and neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Alpha-synuclein expression in substantia nigra and cortex in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

The lysosomal system in neurons. Involvement at multiple stages of Alzheimer's disease pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: a stereological study using the cavalieri and optical disector methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Developmental expression of alpha-synuclein in rat hippocampus and cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Ultrastructural observations in Parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Induction of neuronal death by α-synuclein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Alpha-synuclein in Lewy bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Different rates of age-related loss for four murine monoaminergic neuronal populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Neuropathology in mice expressing human alpha-synuclein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Oxidative stress and genetics in the pathogenesis of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

Etiology of Parkinson's disease: A research strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903514-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(02)03514-X

1 reference

30 November 2017

1 reference